Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1038396

registered interest
date	09/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his policy is on whether decisions on the commissioning of fertility treatment should continue to be the responsibility of clinical commissioning groups.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	206861
answer	answer is ministerial correction date of answer 17/01/2019 answer text <p>The Government has no plans to change arrangements for the commissioning of National Health Service fertility services.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 17/01/2019 17:16:32 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4498 label Biography information for Mr Ranil Jayawardena

1015360

registered interest
date	27/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the potential effect on the price of care purchased by self-funders of local authorities purchasing care packages from the same providers in bulk at a lower unit cost price.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	196209
answer	answer is ministerial correction date of answer 03/12/2018 answer text <p>In its 2017 care home market study, the Competition and Market’s Authority (CMA) considered the potential effects where local authorities pay rates for care packages which are lower than those paid by people who are funding their own care. The CMA’s analysis of this issue and the adult social care market is an important part of the evidence base which will feed into the Green Paper on adult social care. The Green Paper will consider the fundamental issues facing the care system.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 03/12/2018 17:39:56 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4498 label Biography information for Mr Ranil Jayawardena

1012495

registered interest
date	22/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress he has made on the acquisition of Orkambi for the NHS.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	194795
answer	answer is ministerial correction date of answer 27/11/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England are in dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/11/2018 17:11:41 answering member 4067 label Biography information for Steve Brine
tabling member	4498 label Biography information for Mr Ranil Jayawardena

997831

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eyesight: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that there are means of recourse against private sector providers for patients experiencing long-term side effects as a result of laser eye surgery performed by private providers.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	185689
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>Public and private sector providers of laser eye surgery are required by law to register with the Care Quality Commission (CQC) for regulation and doctors in the United Kingdom are required to register with the General Medical Council (GMC). The CQC and the GMC have a range of powers for addressing failures in care.</p><p> </p><p>Providers are also expected to follow the National Institute for Health and Care Excellence (NICE) guidelines on photorefractive (laser) surgery. The CQC, NICE and the Royal College of Ophthalmologists are all clear that the risks and complications of such procedures should be discussed with patients beforehand.</p><p> </p><p>No estimate has been made of the number of people experiencing long-term side effects as a result of laser eye surgery because this data is not held centrally.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 185690 185691 question first answered 05/11/2018 11:08:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4498 label Biography information for Mr Ranil Jayawardena

997849

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eyesight: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that providers of laser eye surgery clearly outline the risks of that procedure to patients prior to such surgery taking place.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	185690
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>Public and private sector providers of laser eye surgery are required by law to register with the Care Quality Commission (CQC) for regulation and doctors in the United Kingdom are required to register with the General Medical Council (GMC). The CQC and the GMC have a range of powers for addressing failures in care.</p><p> </p><p>Providers are also expected to follow the National Institute for Health and Care Excellence (NICE) guidelines on photorefractive (laser) surgery. The CQC, NICE and the Royal College of Ophthalmologists are all clear that the risks and complications of such procedures should be discussed with patients beforehand.</p><p> </p><p>No estimate has been made of the number of people experiencing long-term side effects as a result of laser eye surgery because this data is not held centrally.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 185689 185691 question first answered 05/11/2018 11:08:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4498 label Biography information for Mr Ranil Jayawardena

997850

registered interest
date	30/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eyesight: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people experiencing long-term side effects as a result of laser eye surgery.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	185691
answer	answer is ministerial correction date of answer 05/11/2018 answer text <p>Public and private sector providers of laser eye surgery are required by law to register with the Care Quality Commission (CQC) for regulation and doctors in the United Kingdom are required to register with the General Medical Council (GMC). The CQC and the GMC have a range of powers for addressing failures in care.</p><p> </p><p>Providers are also expected to follow the National Institute for Health and Care Excellence (NICE) guidelines on photorefractive (laser) surgery. The CQC, NICE and the Royal College of Ophthalmologists are all clear that the risks and complications of such procedures should be discussed with patients beforehand.</p><p> </p><p>No estimate has been made of the number of people experiencing long-term side effects as a result of laser eye surgery because this data is not held centrally.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 185689 185690 question first answered 05/11/2018 11:08:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4498 label Biography information for Mr Ranil Jayawardena

902168

registered interest
date	11/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glioblastoma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the causes of changes in the number of cases of (a) brain and (b) glioblastoma multiforme tumours since 1995.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	143213
answer	answer is ministerial correction date of answer 16/05/2018 answer text <p>The changing incidence of cancer is caused primarily by changes in the age of the population. This can be accounted for using an age-standardised rate. Between 2006 and 2015, the age-standardised rate for brain tumours increased from 8.7 per 100,000 to 9.1 per 100,000. However, with a relatively low number of cases it is difficult to be certain that this increase is statistically significant.</p><p> </p><p>Cancer Research UK says that, so far, the scientific evidence shows it is unlikely that mobile phones could increase the risk of brain tumours, or any other type of cancer.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 143214 question first answered 16/05/2018 11:27:00 answering member 4067 label Biography information for Steve Brine
tabling member	4498 label Biography information for Mr Ranil Jayawardena

902171

registered interest
date	11/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glioblastoma: Mobile Phones
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of whether there is a link between mobile phone usage and the increase in number of cases of glioblastoma multiforme tumours since 1995.
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	143214
answer	answer is ministerial correction date of answer 16/05/2018 answer text <p>The changing incidence of cancer is caused primarily by changes in the age of the population. This can be accounted for using an age-standardised rate. Between 2006 and 2015, the age-standardised rate for brain tumours increased from 8.7 per 100,000 to 9.1 per 100,000. However, with a relatively low number of cases it is difficult to be certain that this increase is statistically significant.</p><p> </p><p>Cancer Research UK says that, so far, the scientific evidence shows it is unlikely that mobile phones could increase the risk of brain tumours, or any other type of cancer.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 143213 question first answered 16/05/2018 11:27:00 answering member 4067 label Biography information for Steve Brine
tabling member	4498 label Biography information for Mr Ranil Jayawardena